首页> 外文期刊>The Journal of Urology >Re: Focal Therapy for Localised Unifoeai and Multifocal Prostate Cancer: A Prospective Development Study
【24h】

Re: Focal Therapy for Localised Unifoeai and Multifocal Prostate Cancer: A Prospective Development Study

机译:回复:局部单灶性和多灶性前列腺癌的局灶性治疗:一项前瞻性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Radical whole-gland therapy can lead to significant genitourinary and rectal side-effects for men with localised prostate cancer. We report on whether selective focal ablation of unifocal and multifocal cancer lesions can reduce this treatment burden. Methods: Men aged 45—80 years were eligible for this prospective development study if they had low-risk to high-risk localised prostate cancer (prostate specific antigen [PSA] <=15 ng/mL, Gleason score <4 + 3, stage <=T2), with no previous androgen deprivation or treatment for prostate cancer, and who could safely undergo multiparametric MRI and have a general anaesthetic.
机译:背景:对于患有局限性前列腺癌的男性,根治性全腺疗法可导致显着的泌尿生殖道和直肠副作用。我们报告了选择性聚焦消融的单灶和多灶癌病灶是否可以减轻这种治疗负担。方法:年龄在45-80岁之间的男性,如果患有低危至高危局限性前列腺癌(前列腺特异性抗原[PSA] <= 15 ng / mL,格里森评分<4 + 3,现阶段),则有资格参加这项前瞻性研究<= T2),以前没有雄激素剥夺或治疗前列腺癌的经历,并且可以安全地接受多参数MRI并具有全身麻醉的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号